[{"NetIncomeLoss_1_Q2_USD":-18405000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-1415000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":84676000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-4918000.0,"Depreciation_2_Q2_USD":741000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":203875000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":3808807.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":20000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":14000.0,"AssetsCurrent_0_Q2_USD":358289000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":7.48,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":3328000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":128000.0,"DefinedBenefitPlanAdministrationExpenses_2_Q2_USD":187000.0,"DefinedBenefitPlanAdministrationExpenses_1_Q2_USD":104000.0,"CommonStockSharesIssued_0_Q2_shares":45025857.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q2_USD":0.0,"Assets_0_Q2_USD":368941000.0,"ShareBasedCompensation_2_Q2_USD":1271000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":5985061.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":2.19,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2_Q2_pure":0.04,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":5070554.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":3399174.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":7.48,"TemporaryEquitySharesAuthorized_0_Q2_shares":10000000.0,"AssetsFairValueDisclosure_0_Q2_USD":146681000.0,"ConvertiblePreferredStockSharesIssuedUponConversion_0_Q2_shares":31068102.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":4000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":231172000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-114000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-296000.0,"TemporaryEquitySharesIssued_0_Q2_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":348241000.0,"RestrictedCash_0_Q2_USD":1729000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":231000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-31040000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-18900000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1195000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.0001,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":357060000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":436847000.0,"Liabilities_0_Q2_USD":12263000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":5.52,"GeneralAndAdministrativeExpense_2_Q2_USD":5717000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3486000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"DefinedBenefitPensionPlanLiabilitiesNoncurrent_0_Q2_USD":1472000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-663000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":5562928.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1351000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1019000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-27397000.0,"DefinedContributionPlanEmployerMatchingContributionPercent_2_Q2_pure":1.0,"LiabilitiesCurrent_0_Q2_USD":10791000.0,"AccountsPayableCurrent_0_Q2_USD":7463000.0,"NonoperatingIncomeExpense_2_Q2_USD":-1054000.0,"NonoperatingIncomeExpense_1_Q2_USD":-282000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":358789000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1229000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":128000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_2_Q2_USD":98000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q2_USD":65000.0,"TemporaryEquityValueExcludingAdditionalPaidInCapital_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":84676000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":76950.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":123000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":143000000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":641000.0,"PaymentsOfDividends_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8923000.0,"NetIncomeLoss_2_Q2_USD":-30681000.0,"RestrictedCashNoncurrent_0_Q2_USD":1729000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":14637000.0,"CommonStockSharesOutstanding_0_Q2_shares":44603731.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-78758000.0,"OperatingIncomeLoss_2_Q2_USD":-29627000.0,"OperatingIncomeLoss_1_Q2_USD":-18123000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":206739000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":1619000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q2_USD":-495000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":9.99,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.66,"PaymentsForRepurchaseOfInitialPublicOffering_2_Q2_USD":1395000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":368941000.0,"DividendsPayableCurrentAndNoncurrent_0_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1271000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":374309.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":10274000.0,"OperatingExpenses_2_Q2_USD":29627000.0,"OperatingExpenses_1_Q2_USD":18123000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":844000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-9.03,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-3.63,"ProfitLoss_2_Q2_USD":-30681000.0,"StockholdersEquity_0_Q2_USD":356678000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":4918000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5562928.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":37302.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":315926000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":23910000.0,"Ticker":"GLUE","CIK":"1826457","name":"MONTE ROSA THERAPEUTICS, INC.","OfficialName":"Monte Rosa Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"606660528.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210812"}]